ENTA icon

Enanta Pharmaceuticals
ENTA

Overview Fund Activity

193 hedge funds and large institutions have $1.75B invested in Enanta Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 75 increasing their positions, 57 reducing their positions, and 17 closing their positions.

Holders
193
Holders Change
+12
Holders Change %
+6.63%
% of All Funds
4.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
30
Increased
75
Reduced
57
Closed
17
Calls
$11.5M
Puts
$8.92M
Net Calls
+$2.55M
Net Calls Change
-$475K

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$99.2M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$127M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$44.2M
4
FCM
4
Farallon Capital Management
California
$125M
5
Prudential Financial
5
Prudential Financial
New Jersey
$35.1M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$14.7M
2
First Manhattan
2
First Manhattan
New York
$66M
3
KAM
3
Krensavage Asset Management
New York
$60.2M
4
Man Group
4
Man Group
United Kingdom
$14.9M
5
Millennium Management
5
Millennium Management
New York
$492K
Name Holding Trade Value Shares
Change 		Shares
Change %
FAM
201
Fred Alger Management
New York
– -$324K -4,000 Closed
ARTA
202
A.R.T. Advisors
New York
– -$278K -3,446 Closed
TSS
203
Two Sigma Securities
New York
– -$245K -3,022 Closed
PAM
204
Panagora Asset Management
Massachusetts
– -$118K -1,458 Closed
PA
205
Parallel Advisors
California
– -$28K -348 Closed
AP
206
Advisors Preferred
Maryland
– -$23K -282 Closed
APP
207
Avantax Planning Partners
Iowa
– -$4K -52 Closed
5 6 7 8
9